Early Detection,

Better 

Outcomes.

At Phylomics, we're democratizing access to the next-generation of life-saving cancer screening based our powerful metabolomics platform.

Early detection,

Better Outcomes.

Early detection,

Better Outcomes.

A routine blood draw for 

early cancer detection 

A cancer diagnosis can be scary. With Phylomics, it doesn't have to be. We can easily and accurately detect cancer at its earliest stage making a cancer diagnosis more affordable, treatable, and most importantly, survivable. 

A commonsense approach


Cancer is the result of cells growing and replicating unchecked. As rouge cells grow they produce waste products. We dig through cellular trash that is thrown away in the blood. 


A pioneering process

A Routine Blood Draw

Using a routine blood draw completed during your annual physical we collect the abundant proteins and small molecules produced by tumor cells as they grow.

A Priori Algorithm 

Machine learning training sets and Artificial Intelligence introduce causal bias. We keep things simple, focusing on key evolutionary differences to determine if a harmful mutation is present.

Detection & Treatment Management 

Our easily understood report turns complex proteomic and metabolomic data into clinically actionable insights. The simple visualizations give context to diagnosis, treatment, and prognosis.

Early detection,

Better Outcomes.

At Phylomics, we're democratizing access to the next-generation of life-saving cancer screening based our powerful metabolomics platform.

At Phylomics, we're democratizing access to the next-generation of life-saving cancer screening based on our powerful metabolomics platform.

We use a routine blood draw for

convenient cancer detection 

A cancer diagnosis can be scary. With Phylomics, it doesn't have to be. Our ability to easily and accurately detect cancer at its earliest stages makes cancer more affordable, treatable, and most importantly, survivable. 

Convenient cancer detection 

Proteomics & Metabolomics

Looking for non-cell indicators of real-time changes in gene expression, immune activity, and proteins.

A Priori Algorithm 

Intelligent model decomposes complex genomic, proteomic, and metabolomic datasets to reveal clinically actionable insights.

Pioneering 

Detection & Treatment Tanagement

Our multidimensional tools show the relatedness between subgroups of healthy and diseased individuals and the latter's shared aberrations.

Testimony

The significance of the proposed test that Phylomics is developing cannot be over-emphasized because it will radically reshape the field of medical oncology [...] Such a test will move the medical field beyond personalized medicine to precision medicine

Dr. Christopher Loffredo 

Professor of Oncology and Program Leader for Cancer Prevention, Georgetown University 

Stay in the know,

Don't miss out...

Email* Required field!
View Details
Sold Out